Get started Log in

4592 — SanBio Share News

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSucker Stock

Table: Sanbio -2017/18 parent results
13/03/2018 06:00
Brief: SanBio and Teijin to terminate licensing agreement regarding SB623 for stroke treatment
14/02/2018 09:13
Brief: SanBio and unit receive subsidy of $4.5 mln from CIRM
29/01/2018 01:58
Brief: SanBio and unit receives subsidy of $4.1 mln from CIRM
14/12/2017 02:32
Table: Sanbio - 9-MTH group results
13/12/2017 06:00
Brief: SanBio signs commitment line contract worth 500 mln yen
31/10/2017 05:10
Table: Sanbio - 6-MTH group results
12/09/2017 07:00
Brief: SanBio signs commitment line agreement worth 1.6 bln yen
21/08/2017 08:27
Brief: SanBio receives $20 mln subsidy
30/06/2017 08:49
Table: Sanbio -Q1 group results
14/06/2017 07:00
Brief: SanBio takes out 900 mln yen loan
31/03/2017 07:38
Table: Sanbio -2016/17 group results
21/03/2017 09:30
Table: Sanbio -2016/17 parent results
21/03/2017 09:30
Table: Sanbio -2016/17 group results
17/03/2017 06:00
Table: Sanbio -2016/17 parent results
17/03/2017 06:00
Table: Sanbio -9-MTH group results
14/12/2016 06:00
Brief: SanBio begins clinical trial of regenerative cell medicine for patients with traumatic brain injury
21/09/2016 07:15
Table: Sanbio -6-MTH group results
14/09/2016 07:00
Brief: SanBio says first patient randomizes in STEMTRA trial for traumatic brain injury
11/07/2016 02:41
Table: Sanbio -Q1 group results
14/06/2016 07:00